publicações selecionadas
-
artigo académico
- SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma. Cancers. 2019
- Association between EGF +61 genetic polymorphisms and non-small cell lung cancer increased risk in a Portuguese population: A case-control study. Tumor Biology. 2012
- Decoy activity through microRNAs: the therapeutic implications.. Expert Opin Biol Ther. 2012
- Detection of the Epstein-Barr virus in blood and bone marrow mononuclear cells of patients with aggressive B-cell non-Hodgkin's lymphoma is not associated with prognosis. Oncology Letters. 2012
- BRCA1, microRNAs and cancer predisposition: challenging the dogma.. Cell Cycle. 2011
- MicroRNA history: Discovery, recent applications, and next frontiers. Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis. 2011
- MYC-microRNA-9-metastasis connection in breast cancer. Cell Research. 2010
-
documento
- Redefining ovarian cancer treatment with a first-in-class inhibitor of homologous recombination DNA repair. Annals of Oncology. 2025
- A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancer. Journal of Experimental & Clinical Cancer Research. 2025
- Targeting p53 for melanoma treatment: counteracting tumour proliferation, dissemination and therapeutic resistance 2021
- microRNAs in Cancer: biological effects of microRNAs in colorectal cancer 2012
- Modulation of MicroRNA-194 and cell migration by HER2-targeting trastuzumab in breast cancer 2012
- Long non-coding RNAs and cancer: a new frontier of translational research?. Oncogene. 2012
- MicroRNAs and metastases--the neuroblastoma link. Cancer Biology & Therapy. 2010